Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Progressive Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00950248
What this trial is testing

Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)

Who this might be right for
Primary Progressive Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 85
Testing effectiveness (Phase 2)WithdrawnNCT06841068
What this trial is testing

Intrathecal Amniotic Fluid Stem Cells for Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Progressive
Wake Forest University Health Sciences
Early research (Phase 1)Looking for participantsNCT06138132
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Stanford University 12
Large-scale testing (Phase 3)Study completedNCT01194570
What this trial is testing

Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary Progressive
Hoffmann-La Roche 735
Not applicableStudy completedNCT04918225
What this trial is testing

Motor Asymmetry in Progressive Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
Rennes University Hospital 46
Testing effectiveness (Phase 2)Study completedNCT02284568
What this trial is testing

Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

Who this might be right for
Primary Progressive Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 374
Testing effectiveness (Phase 2)UnknownNCT02273635
What this trial is testing

Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS

Who this might be right for
Primary Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive
Innobioscience SpA 68
Not applicableUnknownNCT04977622
What this trial is testing

Gray Matter Demyelination in Primary Progressive MS at 7T

Who this might be right for
Primary Progressive Multiple Sclerosis
Danish Research Centre for Magnetic Resonance 60
Large-scale testing (Phase 3)Looking for participantsNCT07067463
What this trial is testing

Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) Primary Progressive
Zenas BioPharma (USA), LLC 705
Post-approval studies (Phase 4)Ended earlyNCT01411514
What this trial is testing

Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Claudio Gobbi 27
Testing effectiveness (Phase 2)Study completedNCT02959658
What this trial is testing

Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple Sclerosis
Rigshospitalet, Denmark 54
Post-approval studies (Phase 4)Study completedNCT01970410
What this trial is testing

MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV

Who this might be right for
Multiple Sclerosis
Providence Health & Services 55
Not applicableStudy completedNCT04120675
What this trial is testing

Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Aristotle University Of Thessaloniki 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04035005
What this trial is testing

Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary Progressive
Hoffmann-La Roche 1,013
Not applicableStudy completedNCT04705610
What this trial is testing

Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis (MS) Relapsing RemittingMultiple Sclerosis (MS) Primary Progressive+4 more
Association de Recherche Bibliographique pour les Neurosciences 76
Not applicableLooking for participantsNCT06596746
What this trial is testing

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Who this might be right for
Neurodegenerative DiseasesParkinson DiseaseSynucleinopathies+15 more
Casa di Cura San Raffaele Cassino 600
Testing effectiveness (Phase 2)Looking for participantsNCT05359653
What this trial is testing

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Who this might be right for
Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more
University of California, San Francisco 74
Testing effectiveness (Phase 2)Ended earlyNCT03283826
What this trial is testing

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Atara Biotherapeutics 134
Post-approval studies (Phase 4)Study completedNCT02208050
What this trial is testing

The Effectiveness of Fampridine in Improving Upper Limb Function in MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
University College Dublin 64
Large-scale testing (Phase 3)Study completedNCT04458051
What this trial is testing

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

Who this might be right for
Primary Progressive Multiple Sclerosis
Sanofi 767
Next Page